![Paul Schneider](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Schneider
Financieel Directeur/CFO bij FREELINE THERAPEUTICS HOLDINGS PLC
Actieve functies van Paul Schneider
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FREELINE THERAPEUTICS HOLDINGS PLC | Financieel Directeur/CFO | 16-05-2022 | - |
Directeur/Bestuurslid | 04-04-2023 | 20-02-2024 |
Loopbaan van Paul Schneider
Eerdere bekende functies van Paul Schneider
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Casebia Therapeutics LLC
![]() Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | Corporate Officer/Principal | 01-07-2016 | 01-09-2019 |
Exo Therapeutics, Inc.
![]() Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Operationeel Directeur | - | - |
Financieel Directeur/CFO | - | - |
Opleiding van Paul Schneider
Boston College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Verenigd Koninkrijk | 2 |
Operationeel
Director of Finance/CFO | 2 |
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Freeline Therapeutics Holdings Plc
![]() Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Exo Therapeutics, Inc.
![]() Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA. | Health Technology |
Casebia Therapeutics LLC
![]() Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Paul Schneider
- Ervaring